# OCT Angiography Software Evaluation Study

> **NCT04701931** · — · COMPLETED · sponsor: **Topcon Corporation** · enrollment: 135 (actual)

## Conditions studied

- Retina Condition Followed by Fluorescein Angiography Imaging

## Interventions

- **DEVICE:** Maestro2 OCTA
- **DEVICE:** Cirrus HD-OCT 5000
- **DEVICE:** TRC-50DX

## Key facts

- **NCT ID:** NCT04701931
- **Lead sponsor:** Topcon Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-07
- **Primary completion:** 2022-11-09
- **Final completion:** 2023-06-06
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2023-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04701931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04701931, "OCT Angiography Software Evaluation Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04701931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*